Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011

^{Published on 2011-10-27 18:41:30 - Market Wire}
 

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter... -- SAN DIEGO, Oct. 27, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about CADX

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2011 financial results on Thursday, November 3, 2011.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, November 3, 2011 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at [ www.cadencepharm.com ] and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV™ (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S.  For more information about Cadence, please visit [ www.cadencepharm.com ].

SOURCE Cadence Pharmaceuticals, Inc.

RELATED LINKS
[ http://www.cadencepharm.com ]